Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 34,000 Shares of Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams purchased 34,000 shares of the stock in a transaction on Friday, April 4th. The shares were purchased at an average cost of $0.99 per share, with a total value of $33,660.00. Following the transaction, the director now owns 4,754,800 shares in the company, valued at $4,707,252. This trade represents a 0.72 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Gregg Williams also recently made the following trade(s):

• On Monday, April 7th, Gregg Williams acquired 44,400 shares of Vivani Medical stock. The stock was purchased at an average price of $0.99 per share, with a total value of $43,956.00.
• On Wednesday, April 2nd, Gregg Williams bought 2,000 shares of Vivani Medical stock. The stock was purchased at an average price of $1.01 per share, for a total transaction of $2,020.00.

Vivani Medical Stock Performance

NASDAQ VANI remained flat at $1.02 on Tuesday. 132,928 shares of the company were exchanged, compared to its average volume of 171,944. The business has a fifty day moving average of $1.11 and a 200 day moving average of $1.20. The stock has a market cap of $60.42 million, a price-to-earnings ratio of -2.27 and a beta of 2.76. Vivani Medical, Inc. has a 52 week low of $0.91 and a 52 week high of $2.15.

Vivani Medical (NASDAQ:VANI) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01). On average, analysts expect that Vivani Medical, Inc. will post -0.41 EPS for the current fiscal year.

Institutional Investors Weigh In On Vivani Medical

Hedge funds have recently bought and sold shares of the stock. Wealthedge Investment Advisors LLC purchased a new position in shares of Vivani Medical during the 4th quarter valued at approximately $43,000. Jane Street Group LLC acquired a new stake in Vivani Medical during the fourth quarter valued at $66,000. Northern Trust Corp increased its holdings in Vivani Medical by 19.1% in the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock valued at $83,000 after buying an additional 11,540 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Vivani Medical by 4.6% in the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock worth $401,000 after acquiring an additional 15,008 shares during the period. Hedge funds and other institutional investors own 6.78% of the company’s stock.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “buy” rating and set a $4.00 price objective on shares of Vivani Medical in a research note on Friday.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.